NSVAX vs. SMGIX
Compare and contrast key facts about Columbia Small Cap Value Fund II (NSVAX) and Columbia Contrarian Core Fund (SMGIX).
NSVAX is managed by Columbia. It was launched on May 1, 2002. SMGIX is managed by Columbia. It was launched on Dec 14, 1992.
Performance
NSVAX vs. SMGIX - Performance Comparison
Loading graphics...
NSVAX vs. SMGIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NSVAX Columbia Small Cap Value Fund II | 5.24% | 8.20% | 11.25% | 14.10% | -13.70% | 34.27% | 10.11% | 20.65% | -17.48% | 10.46% |
SMGIX Columbia Contrarian Core Fund | -5.63% | 17.35% | 23.33% | 32.12% | -18.64% | 24.18% | 22.21% | 32.95% | -8.95% | 20.57% |
Returns By Period
In the year-to-date period, NSVAX achieves a 5.24% return, which is significantly higher than SMGIX's -5.63% return. Over the past 10 years, NSVAX has underperformed SMGIX with an annualized return of 9.53%, while SMGIX has yielded a comparatively higher 13.21% annualized return.
NSVAX
- 1D
- 2.33%
- 1M
- -4.16%
- YTD
- 5.24%
- 6M
- 6.70%
- 1Y
- 24.24%
- 3Y*
- 12.66%
- 5Y*
- 6.48%
- 10Y*
- 9.53%
SMGIX
- 1D
- 2.93%
- 1M
- -4.62%
- YTD
- -5.63%
- 6M
- -3.60%
- 1Y
- 15.81%
- 3Y*
- 18.40%
- 5Y*
- 10.92%
- 10Y*
- 13.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NSVAX vs. SMGIX - Expense Ratio Comparison
NSVAX has a 1.02% expense ratio, which is higher than SMGIX's 0.75% expense ratio.
Return for Risk
NSVAX vs. SMGIX — Risk / Return Rank
NSVAX
SMGIX
NSVAX vs. SMGIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia Small Cap Value Fund II (NSVAX) and Columbia Contrarian Core Fund (SMGIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NSVAX | SMGIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | 0.87 | +0.27 |
Sortino ratioReturn per unit of downside risk | 1.70 | 1.34 | +0.36 |
Omega ratioGain probability vs. loss probability | 1.23 | 1.20 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.74 | 1.34 | +0.41 |
Martin ratioReturn relative to average drawdown | 6.73 | 5.64 | +1.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NSVAX | SMGIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 0.87 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.58 | -0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.70 | -0.30 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.68 | -0.25 |
Correlation
The correlation between NSVAX and SMGIX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
NSVAX vs. SMGIX - Dividend Comparison
NSVAX's dividend yield for the trailing twelve months is around 15.10%, more than SMGIX's 7.83% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSVAX Columbia Small Cap Value Fund II | 15.10% | 15.89% | 29.38% | 6.93% | 6.46% | 13.95% | 0.83% | 3.68% | 14.97% | 9.10% | 5.23% | 12.66% |
SMGIX Columbia Contrarian Core Fund | 7.83% | 7.39% | 9.69% | 3.08% | 10.61% | 13.70% | 7.69% | 5.87% | 10.17% | 4.89% | 0.76% | 5.86% |
Drawdowns
NSVAX vs. SMGIX - Drawdown Comparison
The maximum NSVAX drawdown since its inception was -59.32%, which is greater than SMGIX's maximum drawdown of -50.62%. Use the drawdown chart below to compare losses from any high point for NSVAX and SMGIX.
Loading graphics...
Drawdown Indicators
| NSVAX | SMGIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.32% | -50.62% | -8.70% |
Max Drawdown (1Y)Largest decline over 1 year | -14.17% | -12.33% | -1.84% |
Max Drawdown (5Y)Largest decline over 5 years | -27.11% | -32.20% | +5.09% |
Max Drawdown (10Y)Largest decline over 10 years | -48.33% | -32.45% | -15.88% |
Current DrawdownCurrent decline from peak | -5.89% | -7.35% | +1.46% |
Average DrawdownAverage peak-to-trough decline | -9.80% | -6.77% | -3.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.67% | 2.93% | +0.74% |
Volatility
NSVAX vs. SMGIX - Volatility Comparison
Columbia Small Cap Value Fund II (NSVAX) has a higher volatility of 6.18% compared to Columbia Contrarian Core Fund (SMGIX) at 5.29%. This indicates that NSVAX's price experiences larger fluctuations and is considered to be riskier than SMGIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NSVAX | SMGIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.18% | 5.29% | +0.89% |
Volatility (6M)Calculated over the trailing 6-month period | 12.47% | 9.73% | +2.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.72% | 18.74% | +2.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.56% | 19.00% | +3.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.87% | 18.97% | +4.90% |